🇺🇸 FDA

Intelligence · Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs · EMA approved · by data quality · Page 18 of 39

  1. naloxegol

    MOVENTIG

    ORAL FDA: approved · EMA: approved

    A06AH03

  2. natalizumab

    TYSABRI Biogen

    SINGLE-USE FDA: approved · EMA: approved · TGA: approved

    L04AG03

  3. nepafenac

    NEVANAC

    OPHTHALMIC FDA: approved · EMA: approved

    S01BC10

  4. netarsudil

    RHOKIINSA

    DROPS FDA: approved · EMA: approved

    S01EX05

  5. netupitant

    AKYNZEO

    ORAL FDA: approved · EMA: approved

    A04AA

  6. nirmatrelvir

    PAXLOVID

    ORAL FDA: approved · EMA: approved

    J05AE30

  7. nitric oxide

    INOMAX

    INHALATION FDA: approved · EMA: approved

    R07AX

  8. nivolumab

    OPDIVO Bristol-Myers Squibb Australia Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L01FF01

  9. obinutuzumab

    GAZYVA Hoffmann-La Roche

    INJECTION FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L01FA03

  10. ocrelizumab

    OCREVUS Hoffmann-La Roche

    INJECTION FDA: approved · EMA: approved · TGA: approved

    L04AG08

  11. odevixibat

    BYLVAY Ipsen

    ORAL FDA: approved · EMA: approved · TGA: approved

    A05AX

  12. ofatumumab

    KESIMPTA Novartis Pharmaceuticals

    INJECTION FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L04AA52

  13. olaparib

    LYNPARZA AstraZeneca

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L01XK01

  14. omaveloxolone

    SKYCLARYS

    ORAL FDA: approved · EMA: approved

    N07XX25

  15. orlistat

    XENICAL Lacuna Pharma Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    A08AB01

  16. ospemifene

    SENSHIO

    ORAL FDA: approved · EMA: approved

    G03XC05

  17. palbociclib

    IBRANCE Pfizer Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L01EF01

  18. palopegteriparatide

    YORVIPATH

    SUBCUTANEOUS FDA: approved · EMA: approved

    H05AA

  19. panitumumab

    VECTIBIX Amgen

    IV (INFUSION) FDA: approved · EMA: approved · TGA: approved

    L01XC08

  20. peginterferon alfa-2a

    PEGASYS

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved

    L03AB11

  21. peginterferon beta-1a

    PLEGRIDY Biogen

    INJECTION FDA: approved · EMA: approved · TGA: approved

    L03AB13

  22. pegvisomant

    SOMAVERT Pfizer Australia Pty Ltd

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved

    H01AX01

  23. pembrolizumab

    KEYTRUDA Merck KGaA, Darmstadt, Germany

    INJECTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L01FF02

  24. pemetrexed

    PEMETREXED ACCORD Lacuna Pharma Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L01BA04

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.